Christian Czech is currently the Vice President Neuroscience at BIAL, previously holding positions as Senior Director within Pfizer, Therachon, and Roche. With a strong background in neuroscience and rare diseases, Christian has extensive experience leading biomarker groups and developing strategies for clinical and preclinical projects. With a Ph.D. in Molecular Biology from Heidelberg University, Christian has a thorough understanding of preclinical and clinical research in neurodegenerative diseases.